Home - Products - Others - Other Targets - N-trans-p-Coumaroyl-N-trans-feruloyl-3-hydroxy-cadaverine

N-trans-p-Coumaroyl-N-trans-feruloyl-3-hydroxy-cadaverine

CAS No. 2584997-91-9

N-trans-p-Coumaroyl-N-trans-feruloyl-3-hydroxy-cadaverine( —— )

Catalog No. M32599 CAS No. 2584997-91-9

The herbs of Exochorda racemosa.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 691 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    N-trans-p-Coumaroyl-N-trans-feruloyl-3-hydroxy-cadaverine
  • Note
    Research use only, not for human use.
  • Brief Description
    The herbs of Exochorda racemosa.
  • Description
    The herbs of Exochorda racemosa.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2584997-91-9
  • Formula Weight
    470.5
  • Molecular Formula
    C25H30N2O7
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO, Pyridine, Methanol, Ethanol, etc.
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • PACAP-Related Peptid...

    PACAP-Related Peptide (PRP), human,a 29 amino-acid region of the PACAP precursor protein, is synthesized in quantities sufficient for biological and structural studies.

  • 12-Hydroxyganoderic ...

    12-Hydroxyganoderic acid D is a natural product.

  • [Leu144,Arg147]-Myel...

    [Leu144,Arg147]-PLP (139-151) is a mutant peptide fragment of myelin proteolipid protein (PLP), with the tryptophan and histidine at positions 144 and 147 respectively replaced by leucine and arginine. [Leu144,Arg147]-PLP (139-151) also serves as a T cell receptor (TCR) antagonist for encephalitogenic Th1 clones, blocking their activation in vitro. Furthermore, [Leu144,Arg147]-PLP (139-151) can inhibit the development of experimental autoimmune encephalomyelitis (EAE).